arrow
Return

Low-N protein engineering with data-efficient deep learning

delete2021-04-07
delete223
delete
OA
AI
S
Surojit Biswas
G
Grigory Khimulya
E
Ethan C. Alley
K
Kevin M. Esvelt
G
George M. Church *
DOI:10.1038/s41592-021-01100-ydelete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Protein engineering has enormous academic and industrial potential. However, it is limited by the lack of experimental assays that are consistent with the design goal and sufficiently high throughput to find rare, enhanced variants. Here we introduce a machine learning-guided paradigm that can use as few as 24 functionally assayed mutant sequences to build an accurate virtual fitness landscape and screen ten million sequences via in silico directed evolution. As demonstrated in two dissimilar proteins, GFP from Aequorea victoria (avGFP) and E. coli strain TEM-1 beta-lactamase, top candidates from a single round are diverse and as active as engineered mutants obtained from previous high-throughput efforts. By distilling information from natural protein sequence landscapes, our model learns a latent representation of 'unnaturalness', which helps to guide search away from nonfunctional sequence neighborhoods. Subsequent low-N supervision then identifies improvements to the activity of interest. In sum, our approach enables efficient use of resource-intensive high-fidelity assays without sacrificing throughput, and helps to accelerate engineered proteins into the fermenter, field and clinic.
Keywords:
DIRECTED EVOLUTION
FITNESS LANDSCAPE
DESIGN
RECONSTRUCTION
MUTATIONS
EPISTASIS
CONSENSUS
POTENT
SPACE
GENE
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Nature Methods cover
Nature Methods
IF:
32.1
Papers:
7.2K
Citations:
12.7W

Organization

H
Harvard University
Scholars:
26.5W
Papers: 22.0W
Citations: 28.7W
H
Harvard Medical School
Scholars:
6.5W
Papers: 4.8W
Citations: 91
Cited Papers

Cited Papers

Evidence for the Involvement of Vasopressin in the Pathophysiology of Adriamycin-induced Nephropathy in Rats
err2008-12-18
err0
PREAI
errHirokazu Okada; Hiromichi Suzuki; Yoshihiko Kanno; Takao Saruta
errShare
errSave
Hypertrophic Osteoarthropathy
err2013-05-01
err0
PREAI
errCarlos Pineda; Manuel Martínez-Lavín
errShare
errSave
An externally tunable bacterial band-pass filter
err2009-06-23
err150
errOAAI
errSohka, Takayuki; Heins, Richard A.; Phelan, Ryan M.; Greisler, Jennifer M.; Townsend, Craig A.; Ostermeier, Marc
errShare
errSave
Prevalence of Gastrointestinal Symptoms Associated With Diabetes Mellitus
err2001-09-10
err0
PREAI
errPeter Bytzer; Nicholas J. Talley; Melanie Leemon; Lisa J. Young; Michael P. Jones; Michael Horowitz
errShare
errSave
Deep generative models of genetic variation capture the effects of mutations
err2018-09-24
err346
errOAAI
errRiesselman, Adam J.; Ingraham, John B.; Marks, Debora S.
errShare
errSave
Least angle regression
err2004-04-01
err7.5K
errOAAI
errEfron, B; Hastie, T; Johnstone, I; Tibshirani, R
errShare
errSave
errShare
errSave
Unlocking Reactivity of TrpB: A General Biocatalytic Platform for Synthesis of Tryptophan Analogues
err2017-07-14
err101
errOAAI
errRomney, David K.; Murciano-Calles, Javier; Wehrmuller, Jori E.; Arnold, Frances H.
errShare
errSave
researcher View more